Eisai at a glance

Our History - A glance into the history of Eisai

1941

Eisai founded in Japan

2001

First Environmental and Social Report published

1961

Eisai listed on the Tokyo/Osaka stock exchange

2004

European Regional HQ established (London)

1970

Eisai establishes commercial operations in Indonesia

2005

Eisai started marketing Zonegran® (zonisamide) in the US, for the adjunctive treatment of partial-onset seizures in adults

1981

Eisai establishes its North American operation in California

2006

Plans announced for a Strategic European Base in UK

1988

European operations established

2007

Prialt® (ziconotide), for the treatment of severe, chronic pain in patients who require intrathecal (IT) analgesia, launched in Europe

 

Inovelon® (rufinamide) is first launched in Germany, for the treatment of seizures associated with Lennox-Gastaut Syndrome (LGS)

1990

Eisai establishes its UK R&D operation, Eisai London Research Laboratories, at University College London

2008

First Eisai launch of NeuroBloc® (botulinum toxin type B) for cervical dystonia in the UK and Germany

 

1993

Eisai introduces the corporate philosophy of hhc (human health care)

2009

European Knowledge Centre opens in Hatfield, UK as hub of European operations

1996

Commercial operations start in France and Germany

2010

Eisai launches 'aboutmemoryproblems.com' website designed to help people recognise the early signs of Alzheimer's disease and provide guidance for seeking help and advice for those who are concerned about someone close to them

 

Zebinix® (eslicarbazepine acetate) launched in Sweden for the adjunctive treatment of partial-onset seizures in adults

 

Eisai submits regulatory applications for investigational anticancer agent eribulin mesylate (E7389) in Japan, the United States and Europe

 

Eisai subsidiary launched in Canada

1997

Aricept® (donepezil hydrochloride), for the treatment of Alzheimer’s disease, first launched (USA)

2014

Eisai opens its first office in Melbourne, Australia.

Working for Eisai

Eisai regularly has opportunities in a number of functional disciplines. View our current vacancies

human Health Care

Job code Corporate-EU0005 / Date of preparation September 2014